KR102033852B1 - Method for manufacturing Etofenprox intermediate - Google Patents

Method for manufacturing Etofenprox intermediate Download PDF

Info

Publication number
KR102033852B1
KR102033852B1 KR1020180035651A KR20180035651A KR102033852B1 KR 102033852 B1 KR102033852 B1 KR 102033852B1 KR 1020180035651 A KR1020180035651 A KR 1020180035651A KR 20180035651 A KR20180035651 A KR 20180035651A KR 102033852 B1 KR102033852 B1 KR 102033852B1
Authority
KR
South Korea
Prior art keywords
etofenprox
reaction
formula
compound
chloro
Prior art date
Application number
KR1020180035651A
Other languages
Korean (ko)
Other versions
KR20190113240A (en
Inventor
유승원
김형기
Original Assignee
주식회사 한국바르
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 주식회사 한국바르 filed Critical 주식회사 한국바르
Priority to KR1020180035651A priority Critical patent/KR102033852B1/en
Publication of KR20190113240A publication Critical patent/KR20190113240A/en
Application granted granted Critical
Publication of KR102033852B1 publication Critical patent/KR102033852B1/en

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C41/00Preparation of ethers; Preparation of compounds having groups, groups or groups
    • C07C41/01Preparation of ethers
    • C07C41/18Preparation of ethers by reactions not forming ether-oxygen bonds
    • C07C41/24Preparation of ethers by reactions not forming ether-oxygen bonds by elimination of halogens, e.g. elimination of HCl
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N31/00Biocides, pest repellants or attractants, or plant growth regulators containing organic oxygen or sulfur compounds
    • A01N31/08Oxygen or sulfur directly attached to an aromatic ring system
    • A01N31/14Ethers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C31/00Saturated compounds having hydroxy or O-metal groups bound to acyclic carbon atoms
    • C07C31/02Monohydroxylic acyclic alcohols
    • C07C31/12Monohydroxylic acyclic alcohols containing four carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00Ethers; Compounds having groups, groups or groups
    • C07C43/02Ethers
    • C07C43/20Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring
    • C07C43/205Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring the aromatic ring being a non-condensed ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00Ethers; Compounds having groups, groups or groups
    • C07C43/02Ethers
    • C07C43/257Ethers having an ether-oxygen atom bound to carbon atoms both belonging to six-membered aromatic rings
    • C07C43/263Ethers having an ether-oxygen atom bound to carbon atoms both belonging to six-membered aromatic rings the aromatic rings being non-condensed

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Dentistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Plant Pathology (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Pest Control & Pesticides (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Agronomy & Crop Science (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

본 발명은 Etofenprox 중간체인 2-(4-Ethoxyphenyl)-2-methylpropan-1-ol 의 효율적으로 제조하는 방법으로서 기존 공정보다 쉽고 수율을 증가할 수 있으며, Etofenprox 개발시 유용하게 사용될 수 있는 Etofenprox 중간체 제조방법에 관한 것이다.The present invention is a method for efficiently preparing the 2- (4-Ethoxyphenyl) -2-methylpropan-1-ol, which is an Etofenprox intermediate, can easily increase the yield than the conventional process, and can be used in the development of Etofenprox. It is about a method.

Description

에토펜프록스 중간체 제조방법{Method for manufacturing Etofenprox intermediate}Method for manufacturing Etofenprox intermediate

본 발명은 Etofenprox 중간체인 2-(4-Ethoxyphenyl)-2-methylpropan-1-ol 의 효율적으로 제조하는 방법으로서 기존 공정보다 쉽고 수율을 증가할 수 있으며, Etofenprox 개발시 유용하게 사용될 수 있는 Etofenprox 중간체 제조방법에 관한 것이다.The present invention is a method for efficiently preparing the 2- (4-Ethoxyphenyl) -2-methylpropan-1-ol, which is an Etofenprox intermediate, can easily increase the yield than the conventional process, and can be used in the development of Etofenprox. It is about a method.

Etofenprox는 일본 미쯔이社에서 개발한 pyrethroid계 살충제이고 IUPAC명은 2-(4-ethoxyphenyl)-2- methylpropyl 3-phenoxybenzyl 이다. 직접 접촉 혹은 섭취 후 곤충신경계를 파괴하는 메카니즘을 가지는 살충제이다. 사용되는 주요농작물은 쌀, 채소, 옥수수, 과일농작물, 콩 재배에 사용되고 주로 북미, 유럽, 아시아 특히 미국, 독일, 일본 그리고 중국 등에서 많이 사용되고 있으며 세계적으로 사용 양이 수백 톤에 이르는 살충제이다.Etofenprox is a pyrethroid insecticide developed by Mitsui, Japan, and its IUPAC name is 2- (4-ethoxyphenyl) -2-methylpropyl 3-phenoxybenzyl. It is a pesticide with a mechanism that destroys the insect nervous system after direct contact or ingestion. The main crops used are rice, vegetables, corn, fruit crops and soybeans, and are mainly used in North America, Europe, Asia, especially the United States, Germany, Japan and China.

[Etofenprox 구조식]Etofenprox structural formula

Figure 112018030710240-pat00001
Figure 112018030710240-pat00001

2-(4-Ethoxyphenyl)-2-methylpropan-1-ol은 Etofenprox 제조시 사용되는 핵심 중간체로서 기존 제조 공정은 어렵고 원가가 높은 화합물을 사용하고 있다. 많은 특허기술에서 언급하였지만 대량생산에는 적용하기 힘든 공정들이다.2- (4-Ethoxyphenyl) -2-methylpropan-1-ol is a key intermediate used in the manufacture of Etofenprox, which uses a compound that is difficult and expensive to manufacture. Although mentioned in many patented technologies, they are difficult to apply to mass production.

[기존 제조 공정][Existing Manufacturing Process]

Figure 112018030710240-pat00002
Figure 112018030710240-pat00002

Etofenprox구조는 para위치에 기능기가 있는 화합물이다. 그런데 ethoxybenzene에서 Fridelcraft 반응시에는 o-, p- 위치에 치환된 ethoxybenzene유도체가 생성되는데 o-위치에 치환된 화합물이 같이 생성되어 분리하기가 어려워 쉽게 합성될 수 없는 어려움이 있다.Etofenprox is a compound with a functional group at the para position. However, in the ethoxybenzene, the Fridelcraft reaction produces ethoxybenzene derivatives substituted at the o- and p-positions, and the compounds substituted at the o-positions are also difficult to separate and thus cannot be easily synthesized.

[Fridelcraft 반응][Fridelcraft Reaction]

Figure 112018030710240-pat00003
Figure 112018030710240-pat00003

이러한 문제를 극복하기 위해 Fridelcraft 반응을 하지 않고 생성 가능한 공정이 나왔고, 아래와 같이 para위치에 기능기를 가지는 화합물을 출발물질로 하여 여러단계를 거쳐 핵심 중간체인 alcohol화합물을 제조하고 있다. 그러나 아래 제조공정 1은 공정이 많아서 alcohol화합물의 단가가 높은 문제가 있다.In order to overcome this problem, a process that can be produced without a Fridelcraft reaction has emerged, and the alcohol compound, which is a key intermediate, is prepared through several steps using a compound having a functional group at a para position as a starting material as follows. However, the manufacturing process 1 below has a problem that the cost of alcohol compounds is high because there are many processes.

[제조공정 1][Manufacturing Process 1]

Figure 112018030710240-pat00004
Figure 112018030710240-pat00004

그리고 제조공정 2는 그리냐드(Grignard) 반응으로서 반응조건이 까다롭고 수율이 낮아 지속적인 공급을 확신할 수 없어 장기적으로는 문제점이 대두되고 있다.In addition, the manufacturing process 2 is a Grignard reaction, and the reaction conditions are difficult and the yield is low. Therefore, the continuous supply cannot be assured, causing problems in the long term.

[제조공정 2][Manufacturing Process 2]

Figure 112018030710240-pat00005
Figure 112018030710240-pat00005

대한민국 등록특허 10-0923835Republic of Korea Patent Registration 10-0923835 대한민국 공개특허 10-2017-0101275Republic of Korea Patent Publication 10-2017-0101275 대한민국 공개특허 10-2016-0113719Republic of Korea Patent Publication 10-2016-0113719

이에 본 발명은 상기와 같은 문제점을 해결하기 위해 안출된 것으로서, 본 특허의 핵심 기술의 첫 번째는 ortho 및 para 위치에 chloro가 치환된 디클로로화합물을 얻은 다음, 두 번째는 정제하지 않은 디클로로화합물을 아세테이트화하고, 이를 가수분해와 동시에 탈염소화 하여 원하는 2-(4-Ethoxyphenyl)-2-methylpropan-1-ol (순도 98% 이상)을 결정으로 얻는 공정을 채택함으로써, 공정을 단순화하고, 대량 생산시 비용을 줄일 수 있으며, 저가의 Etofenprox 중간체를 얻어 기존 공정과 경쟁시 우위를 점할 수 있는 Etofenprox 중간체 제조방법을 제공하는 것이다.Accordingly, the present invention has been made to solve the above problems, the first of the core technology of the patent obtains a dichloro compound substituted with chloro in the ortho and para position, the second is a dichloro compound unpurified acetate And the process of dechlorination at the same time as hydrolysis to obtain the desired 2- (4-Ethoxyphenyl) -2-methylpropan-1-ol (at least 98% purity) as crystals, simplifying the process and It is possible to reduce the cost and to obtain a low cost Etofenprox intermediate to provide a method for producing an Etofenprox intermediate that can compete with existing processes.

본 발명의 해결하고자 하는 과제는 이상에서 언급된 것들에 한정되지 않으며, 언급되지 아니한 다른 해결과제들은 아래의 기재로부터 당업자에게 명확하게 이해되어 질 수 있을 것이다.The problem to be solved of the present invention is not limited to those mentioned above, other problems not mentioned will be clearly understood by those skilled in the art from the following description.

이를 위해 본 발명에 따른 Etofenprox 중간체 제조방법은 클로로에톡시벤젠을 황산 및 클로로알켄과 반응시켜 디클로로화합물을 제조하는 S1단계와; 상기 디클로로화합물을 금속 아세테이트 염과, 염기와, 용매와, 반응 촉매와 반응시켜 클로로아세테이트화합물을 제조하는 S2단계와; 상기 클로로아세테이트화합물을 염기와, 용매와, 반응 촉매와 반응시켜 알콜화합물을 제조하는 S3단계;를 포함하는 것을 특징으로 한다. 상기 S2단계의 금속 아세테이트 염은 알칼리 금속 및 알칼리 토금속의 아세테이트 염으로 이루어지는 것을 특징으로 한다.To this end, the method for preparing an Etofenprox intermediate according to the present invention comprises the step S1 of preparing a dichloro compound by reacting chloroethoxybenzene with sulfuric acid and chloroalkene; A step S2 of reacting the dichloro compound with a metal acetate salt, a base, a solvent, and a reaction catalyst to produce a chloroacetate compound; And a step S3 of preparing an alcoholic compound by reacting the chloroacetate compound with a base, a solvent, and a reaction catalyst. The metal acetate salt of step S2 is characterized by consisting of acetate salts of alkali metals and alkaline earth metals.

또한, 본 발명에 따른 Etofenprox 중간체 제조방법에 있어서, 염기는 탄산알칼리금속, 수산화알칼리금속, 암모니아수 및 트리알킬아민으로 이루어지는 군으로부터 선택되는 것을 특징으로 한다.In addition, in the method for producing an Etofenprox intermediate according to the present invention, the base is selected from the group consisting of alkali metal carbonate, alkali metal hydroxide, ammonia water and trialkylamine.

또한, 본 발명에 따른 Etofenprox 중간체 제조방법에 있어서, 탄산알칼리금속은 탄산나트륨 또는 탄산칼륨이고, 상기 수산화알킬리금속은 탄산수소나트륨, 산화나트륨 또는 수산화칼륨이고, 상기 트리알킬아민은 트리메틸아민인 것을 특징으로 한다.In addition, in the method for producing an Etofenprox intermediate according to the present invention, the alkali metal carbonate is sodium carbonate or potassium carbonate, the alkyl hydroxide metal is sodium bicarbonate, sodium oxide or potassium hydroxide, and the trialkylamine is trimethylamine. It is done.

또한, 본 발명에 따른 Etofenprox 중간체 제조방법에 있어서, 용매는 물, N-메틸 피롤리딘, N,N-디메틸이미다졸리디논으로 이루어지는 군으로부터 선택되는 것을 특징으로 한다.In addition, in the method for producing an Etofenprox intermediate according to the present invention, the solvent is characterized in that it is selected from the group consisting of water, N-methyl pyrrolidine, N, N-dimethylimidazolidinone.

이에 본 발명은 상기와 같은 문제점을 해결하기 위해 안출된 것으로서, 본 발명에 따른 Etofenprox 중간체 제조방법은 Etofenprox 중간체인 2-(4-Ethoxyphenyl)-2- methyl propan-1-ol 을 효율적으로 제조함으로써 기존 공정보다 쉽게 단순화할 수 있으며, 수율을 증가하여 저가의 Etofenprox 개발시 유용하게 사용할 수 있는 효과가 있다.Accordingly, the present invention has been made to solve the above problems, the method for preparing an Etofenprox intermediate according to the present invention by efficiently preparing the 2- (4-Ethoxyphenyl) -2-methyl propan-1-ol which is an Etofenprox intermediate The process is simpler than the process, and the yield is increased, which is useful for developing low-cost Etofenprox.

본 발명의 효과는 이상에서 언급된 것들에 한정되지 않으며, 언급되지 아니한 다른 해결과제들은 아래의 기재로부터 당업자에게 명확하게 이해되어 질 수 있을 것이다.The effects of the present invention are not limited to those mentioned above, and other problems not mentioned will be clearly understood by those skilled in the art from the following description.

도 1은 실시예 1의 2-클로로-4-(1-클로로-2-메틸프로판-2-일)-1-에톡시벤젠의 1H-NMR 스펙트럼을 나타낸 것이고,
도 2는 실시예 2의 2-(3-클로로-4-에톡시페닐)-2-메틸프로필 아세테이트의 1H-NMR 스펙트럼을 나타낸 것이며,
도 3은 실시예 2의 2-(3-클로로-4-에톡시페닐)-2-메틸프로필 아세테이트의 13C-NMR 스펙트럼을 나타낸 것이고,
도 4는 실시예 3의 2-(4-에톡시페닐)-2-메틸프로판-1-올의 1H-NMR 스펙트럼을 나타낸 것이다.
1 shows the 1H-NMR spectrum of 2-chloro-4- (1-chloro-2-methylpropan-2-yl) -1-ethoxybenzene of Example 1,
2 shows the 1H-NMR spectrum of 2- (3-chloro-4-ethoxyphenyl) -2-methylpropyl acetate of Example 2,
3 shows the 13C-NMR spectrum of 2- (3-chloro-4-ethoxyphenyl) -2-methylpropyl acetate of Example 2,
Figure 4 shows the 1H-NMR spectrum of 2- (4-ethoxyphenyl) -2-methylpropan-1-ol of Example 3.

이하, 본 발명의 실시예를 상세히 설명하면 다음과 같다.Hereinafter, an embodiment of the present invention will be described in detail.

본 발명을 설명함에 있어서, 관련된 공지기능 혹은 구성에 대한 구체적인 설명이 본 발명의 요지를 불필요하게 흐릴 수 있다고 판단되는 경우 그 상세한 설명은 생략한다. 또한, 후술되는 용어들은 본 발명에서의 기능을 고려하여 정의된 용어들로서 이는 사용자, 운용자의 의도 또는 판례 등에 따라 달라질 수 있다. 그러므로 그 정의는 본 명세서 전반에 걸친 내용을 토대로 내려져야 할 것이다.In describing the present invention, if it is determined that the detailed description of the related known function or configuration may unnecessarily obscure the subject matter of the present invention, the detailed description thereof will be omitted. In addition, terms to be described below are terms defined in consideration of functions in the present invention, which may vary according to intention or precedent of a user or an operator. Therefore, the definition should be made based on the contents throughout the specification.

본 발명은 하기 화학식 4로 표시되는 Etofenprox 중간체인 2-(4-Ethoxyphenyl)-2- methyl propan-1-ol (I)을 제공한다. The present invention provides 2- (4-Ethoxyphenyl) -2-methyl propan-1-ol (I), which is an Etofenprox intermediate represented by the following formula (4).

[화학식 4][Formula 4]

Figure 112018030710240-pat00006
Figure 112018030710240-pat00006

화학식 4로 표시되는 Etofenprox 중간체의 제조 과정은 하기 반응식 1과 같다.The preparation process of the Etofenprox intermediate represented by Formula 4 is shown in Scheme 1 below.

[반응식 1]Scheme 1

Figure 112018030710240-pat00007
Figure 112018030710240-pat00007

첫 단계인 Fridelcraft 반응은 아래 반응식 1-1에 표시된 바와 같이 목적화합물인 디클로로화합물(2)의 수율을 최대화하고 부반응물이 적게 생성되는 조건을 수립하였다.The first step, the Fridelcraft reaction, established the conditions for maximizing the yield of dichloro compound (2) as a target compound and generating less side reactions, as shown in Scheme 1-1 below.

[반응식 1-1] Fridelcraft 반응Scheme 1-1 Fridelcraft reaction

Figure 112018030710240-pat00008
Figure 112018030710240-pat00008

바람직하게는 클로로알켄 1당량에 황산 0.5~2.0 당량과 클로로에톡시벤젠(1) 1~3 당량 사용하는 것이며, 보다 바람직하게는 클로로알켄 1 당량에 황산 0.7~1 당량과 클로로에톡시벤젠(1) 1.5~2 당량을 사용하는 것이다. 여기서, 반응온도는 바람직하게는 -10~10℃이며, 보다 바람직하게는 -5~0℃인 것을 예시할 수 있다.Preferably, 0.5 equivalent to 2.0 equivalents of sulfuric acid and 1 to 3 equivalents of chloroethoxybenzene (1) are used in 1 equivalent of chloroalkenes, and more preferably 0.7-1 equivalents of sulfuric acid and chloroethoxybenzene (1) are used in 1 equivalent of chloroalkenes. ) 1.5 to 2 equivalents. Here, reaction temperature becomes like this. Preferably it is -10-10 degreeC, More preferably, it can illustrate that it is -5-0 degreeC.

두 번째 단계인 아세테이트 반응은 아래 반응식 1-2에 표시된 바와 같이 목적화합물인 아세테이트화합물(3)의 수율을 최대화하고 부반응물이 적게 생성되는 조건을 수립하였다.As a second step, the acetate reaction was established to maximize the yield of the target compound acetate compound (3) and to produce less side reactions, as shown in Scheme 1-2 below.

[반응식 1-2] 아세테이트 반응Reaction Scheme 1-2

Figure 112018030710240-pat00009
Figure 112018030710240-pat00009

여기서, potassium acetate의 비율은 디클로로 화합물(2) 1.0 당량에 바람직하게는 1.0~5.0 당량 사용하는 것이며 보다 바람직하게는 2.0~4.0 당량 사용하는 것이다. 반응온도는 바람직하게는 80~200℃이며, 보다 바람직하게는 110~130℃이다.Here, the proportion of potassium acetate is preferably 1.0 to 5.0 equivalents, more preferably 2.0 to 4.0 equivalents, for 1.0 equivalent of dichloro compound (2). Reaction temperature becomes like this. Preferably it is 80-200 degreeC, More preferably, it is 110-130 degreeC.

반응 용매는 고온 반응에 유용한 DMSO, DMF, NMP, DMI이며 바람직하게는 NMP, DMI 용매 사용하는 것이다. 보다 더 쉽게 아세테이트화하기 위해 반응 촉매로 테트라부틸암모늄브로마이드(TBAB)를 사용하는데, 그 비율은 디클로로 화합물(2) 1.0 당량에 바람직하게는 0.5~2.0 당량 사용하는 것이며, 보다 바람직하게는 0.7~1.0 당량 사용하는 것이다. 본 발명에 따른 제조방법에 있어서, 사용되는 염기는 탄산나트륨, 탄산칼륨 등의 탄산알칼리금속; 탄산수소나트륨, 산화나트륨, 수산화칼륨 등의 수산화알칼리금속; 암모니아수; 트리메틸아민 등의 트리알킬아민 등을 들 수 있다.The reaction solvent is DMSO, DMF, NMP, DMI useful for high temperature reaction, and preferably NMP, DMI solvent is used. Tetrabutylammonium bromide (TBAB) is used as a reaction catalyst for easier acetate formation, and the ratio is preferably 0.5 to 2.0 equivalents, more preferably 0.7 to 1.0 equivalents, for 1.0 equivalent of dichloro compound (2). It is equivalent to using. In the production method according to the present invention, the base used may be an alkali metal carbonate such as sodium carbonate or potassium carbonate; Alkali metal hydroxides such as sodium bicarbonate, sodium oxide and potassium hydroxide; ammonia; Trialkylamines, such as trimethylamine, etc. are mentioned.

세 번째 단계인 가수분해 및 탈염소 반응은 아래 반응식 1-3에 표시된 바와 같이 목적화합물인 알콜화합물(I)의 수율을 최대화하고 부반응물이 적게 생성되는 조건을 수립하였다.The third step, hydrolysis and dechlorination reaction, established the conditions for maximizing the yield of alcohol compound (I) as a target compound and generating less side reactions, as shown in Schemes 1-3 below.

[반응식 1-3] 가수분해 및 탈염소 반응Scheme 1-3 Hydrolysis and Dechlorination

Figure 112018030710240-pat00010
Figure 112018030710240-pat00010

여기서, 사용되는 염기는 수산화칼륨과 수산화나트륨인 것을 예시할 수 있으나, 이에 한정되는 것은 아니고 탄산나트륨, 탄산칼륨 등의 탄산알칼리금속 및 탄산수소나트륨, 암모니아수, 트리메틸아민 등의 트리알킬아민을 사용할 수 있다.Here, examples of the base used may include potassium hydroxide and sodium hydroxide, but are not limited thereto, and alkali metal carbonates such as sodium carbonate and potassium carbonate and trialkylamines such as sodium bicarbonate, ammonia water and trimethylamine may be used. .

그리고 염기는 클로로아세테이트화합물(3) 1.0 당량에 바람직하게는 10.0~3.0 당량 사용하는 것이며, 보다 바람직하게는 4.0~7.0 당량 사용하는 것이다. 탈염소화 반응에 사용되는 금속은 일반적으로 Pd/C, PdCl2, PtO2 등을 사용할 수 있으며 바람직하게는 5% Pd/C을 사용하는 것이다.The base is preferably 10.0 to 3.0 equivalents, more preferably 4.0 to 7.0 equivalents, in 1.0 equivalent of chloroacetate compound (3). The metal used in the dechlorination reaction may generally use Pd / C, PdCl 2 , PtO 2 , and the like, and preferably 5% Pd / C.

반응용매는 무기염기를 녹일 수 있는 극성용매인 DMSO, DMF, Dioxane, 메탄올, 에탄올이 사용될 수 있으며, 바람직하게는 메탄올, 에탄올 용매를 사용하는 것이다.As the reaction solvent, DMSO, DMF, Dioxane, methanol, and ethanol, which are polar solvents capable of dissolving inorganic bases, may be used. Preferably, methanol, ethanol solvents are used.

반응온도는 바람직하게는 20~100℃이며 보다 바람직하게는 50~70℃이다. Reaction temperature becomes like this. Preferably it is 20-100 degreeC, More preferably, it is 50-70 degreeC.

마지막으로, 네 번째 재결정 단계는 반응식 1-3에서 얻어진 알콜화합물(I)을 비극성 용매로 사용하여 재결정하는 단계이다.Finally, the fourth recrystallization step is a step of recrystallization using the alcohol compound (I) obtained in Scheme 1-3 as a nonpolar solvent.

이때 사용하는 용매는 비극성 용매인 헥산, 헵탄, 톨루엔, 크실렌 등을 사용 하였고, 이때 crude 알콜(I) 1.0 부피에 바람직하게는 2.0~10.0 부피를 사용하는 것이며, 보다 바람직하게는 3.0~5.0 부피를 사용하는 것이다.In this case, non-polar solvents such as hexane, heptane, toluene, and xylene were used. In this case, preferably 1.0 to 10.0 volumes of crude alcohol (I) is used, and more preferably 3.0 to 5.0 volumes. Is to use.

이하, 실시예를 통해서 본 발명을 더욱 상세히 설명하기로 한다.Hereinafter, the present invention will be described in more detail with reference to Examples.

2-2- 클로로Chloro -4-(1--4- (1- 클로로Chloro -2--2- 메틸프로판Methylpropane -2-일)-1--2-yl) -1- 에톡시벤젠Ethoxybenzene (2)의 합성 Synthesis of (2)

3구 플라스크에 헵탄 10ml을 넣고, 1-클로로-2-에톡시벤젠 10g을 가해 교반한다. 진한 황산 4g을 -5~0℃ 범위 내에서 약 1시간 동안 적가한다. 진한 황산 적가 완료 후 3-클로로-2-메틸프로펜 5g을 약 1시간 동안 반응액에 적가한다. 적가 완료 후 플라스크 외부의 얼음 중탕기를 제거하고 자연스럽게 반응기의 온도를 실온까지 상승시켜 추가 2시간 교반하여 준다.(단 20 ℃는 넘지 않게 해준다)10 ml of heptane is added to a three neck flask, and 10 g of 1-chloro-2-ethoxybenzene is added and stirred. 4 g of concentrated sulfuric acid is added dropwise for about 1 hour in the range of -5 to 0 ° C. After completion of the concentrated dropwise addition of 5 g of 3-chloro-2-methylpropene was added dropwise to the reaction solution for about 1 hour. After completion of the dropping, remove the ice bath outside the flask and naturally warm the reactor to room temperature and stir for an additional 2 hours (but do not exceed 20 ° C).

반응종결 상태를 HPLC로 확인하고 헵탄 100ml,물 100ml를 차례로 가하고 반응액을 정치시킨 다음, 정치시킨 반응액에서 헵탄층을 분리하고 황산나트륨 3g을 이용하여 헵탄내의 수분을 탈수하고 감압 증류하여 디클로로화합물인 2- 클로로 -4-(1-클로로-2- 메틸프로판 -2-일)-1- 에톡시벤젠(2) 12g (수율 76%)을 얻었다.After confirming the completion of reaction by HPLC, 100 ml of heptane and 100 ml of water were added sequentially, and the reaction solution was allowed to stand. Then, the heptane layer was separated from the reaction mixture, and the water in heptane was dehydrated using 3 g of sodium sulfate and distilled under reduced pressure. 2-chloro-4- (1-chloro-2-methyl-propan-2-yl) -1-ethoxy-benzene (2) was obtained 12g (yield 76%).

1H NMR (400 MHz, CDCl3)δ7.40(d,J= 2.3 Hz, 1H), 7.21 (dd, J= 8.7, 2.4 Hz, 1H), 6.91 (d, J= 8.4 Hz, 1H), 4.13 (q, 2H), 3.63 (s, 2H), 1.49 (t, J= 6.8 Hz, 3H), 1.41 (s, 6H) 1 H NMR (400 MHz, CDCl 3 ) δ 7.40 (d, J = 2.3 Hz, 1H), 7.21 (dd, J = 8.7, 2.4 Hz, 1H), 6.91 (d, J = 8.4 Hz, 1H), 4.13 (q, 2H), 3.63 (s, 2H), 1.49 (t, J = 6.8 Hz, 3H), 1.41 (s, 6H)

2-(3-2- (3- 클로로Chloro -4--4- 에톡시페닐Ethoxyphenyl )-2-)-2- 메틸프로필Methylpropyl 아세테이트(3)의 합성 Synthesis of Acetate (3)

준비된 3구 플라스크에 N-메틸-2-피롤리디논 5ml, 2-클로로-4-(1-클로로-2-메틸프로판-2-일)-1-에톡시벤젠 10g, 포타시움 아세테이트 12g 및 포타시움 카보네이트 1g을 차례로 넣는다. 그리고 반응촉매로 테트라뷰틸암모니움브로마이드 3g을 넣고 180℃에서 18~20시간 동안 교반한다.In a prepared three-necked flask, 5 ml of N-methyl-2-pyrrolidinone, 10 g of 2-chloro-4- (1-chloro-2-methylpropan-2-yl) -1-ethoxybenzene, 12 g of potassium acetate, and potassium carbonate Add 1 g in sequence. Then, add 3 g of tetrabutylammonium bromide as a reaction catalyst and stir at 180 ° C. for 18-20 hours.

반응 종결 후 반응액의 온도를 실온으로 천천히 냉각시킨 후 에틸아세테이트 100ml를 반응액에 넣고 물 100ml를 이용하여 에틸아세테이트층을 세척해준다. 에틸아세테이트 층을 무수 황산나트륨 5g을 이용하여 에틸아세테이트 층 내의 수분을 없애주고 감압 증류하여 클로로아세테이트화합물인 2-(3- 클로로 -4- 에톡시페닐 )-2-메틸프로필 아세테이트(3) 8.8g (수율 80%)을 얻는다.After completion of the reaction, the temperature of the reaction solution was slowly cooled to room temperature, and 100 ml of ethyl acetate was added to the reaction solution, and the ethyl acetate layer was washed with 100 ml of water. 8.8 g of ethyl acetate layer (5) of 2- (3 -chloro- 4 -ethoxyphenyl ) -2-methylpropyl acetate , a chloroacetate compound, was removed by distillation under reduced pressure using 5 g of anhydrous sodium sulfate to remove moisture in the ethyl acetate layer. Yield 80%).

1HNMR(400MHz,CDCl3) δ7.38 (d,J= 2.4 Hz, 1H), 7.20 (dd, J= 8.6, 2.4 Hz, 1H), 6.89 (d, J= 8.6 Hz, 1H), 4.12 (dd, J= 15.1, 8.1 Hz, 4H), 2.04 (s, 3H), 1.48 (t, J= 7.0 Hz, 3H), 1.35 (s, 6H). 13CNMR (101MHz,CDCl3) δ171.02,152.73,139.38,128.11,125.11,122.45,113.04,72.82,64.71,37.62,25.81,20.87,14.75. 1 HNMR (400 MHz, CDCl 3 ) δ7.38 (d, J = 2.4 Hz, 1H), 7.20 (dd, J = 8.6, 2.4 Hz, 1H), 6.89 (d, J = 8.6 Hz, 1H), 4.12 ( dd, J = 15.1, 8.1 Hz, 4H), 2.04 (s, 3H), 1.48 (t, J = 7.0 Hz, 3H), 1.35 (s, 6H). 13 CNMR (101 MHz, CDCl 3) δ 171.02,152.73,139.38,128.11,125.11,122.45,113.04,72.82,64.71,37.62,25.81,20.87,14.75.

2-(4-2- (4- 에톡시페닐Ethoxyphenyl )-2-)-2- 메틸프로판Methylpropane -1-올(I)의 합성 Synthesis of -1-ol (I)

메탄올 15ml에 2-(3-클로로-4-에톡시페닐)-2-메틸프로필 아세테이트 3g을 넣고 녹인다. 물 5ml에 포타시움하이드록사이드 3.7g을 녹여 위 용액에 가한다. 5% 팔라디움 0.1g을 반응액에 넣고 약 5기압의 수소압을 유지하며 70℃에서 18시간 동안 반응시킨다.Dissolve 3 g of 2- (3-chloro-4-ethoxyphenyl) -2-methylpropyl acetate in 15 ml of methanol. Dissolve 3.7 g of Potassium Hydroxide in 5 ml of water and add to the stomach solution. 0.1 g of 5% palladium is added to the reaction solution, and the reaction is carried out at 70 ° C. for 18 hours while maintaining a hydrogen pressure of about 5 atmospheres.

반응 종결 후 감압하여 여과하고 여액에 에틸아세테이트 80ml를 가하고 물 80ml씩 3회 유기층을 세척하여 준다. 에틸아세테이트층을 무수황산나트륨 5g으로 탈수하여주고 여과, 감압 증류하면 최종 목적화합물 1.72g (수율 80%)을 얻는다.After completion of the reaction, the mixture was filtered under reduced pressure, 80 ml of ethyl acetate was added to the filtrate, and the organic layer was washed three times with 80 ml of water. The ethyl acetate layer was dehydrated with 5 g of anhydrous sodium sulfate, filtered and distilled under reduced pressure to obtain 1.72 g (yield 80%) of the final target compound.

1HNMR (400MHz,DMSO) δ7.27(d,J= 8.8 Hz, 2H), 6.84 (d, J= 8.8, Hz, 2H), 3.98 (q, 2H), 3.38 (s, 2H), 1.32 (t, J= 9.8 Hz, 3H), 1.20 (s, 6H). 1 HNMR (400 MHz, DMSO) δ 7.27 (d, J = 8.8 Hz, 2H), 6.84 (d, J = 8.8, Hz, 2H), 3.98 (q, 2H), 3.38 (s, 2H), 1.32 ( t, J = 9.8 Hz, 3H), 1.20 (s, 6H).

한편, 본 발명의 상세한 설명에서는 구체적인 실시예에 관해 설명하였으나, 본 발명은 개시된 실시예에 한정되지 않고 본 발명이 속하는 기술분야에서 통상의 지식을 가진 자에게 있어 본 발명의 기술적 사상을 벗어나지 않는 범위 내에서 여러 가지 치환, 변형 및 변경이 가능하다. 따라서, 본 발명의 범위는 설명된 실시예에 국한되어 정해져서는 안되며 후술하는 특허청구범위뿐만 아니라 이 특허청구범위와 균등한 것들을 포함하는 것으로 해석되어야 할 것이다.On the other hand, in the detailed description of the present invention has been described with respect to specific embodiments, the present invention is not limited to the disclosed embodiments, but a range that does not depart from the spirit of the present invention for those skilled in the art to which the present invention pertains. Various substitutions, modifications and variations are possible within the scope of the invention. Therefore, the scope of the present invention should not be limited to the described embodiments, but should be construed as including not only the claims below but also equivalents thereof.

Claims (5)

하기 화학식 1로 표시되는 클로로에톡시벤젠을 황산 및 3-클로로-2-메틸프로펜과 반응시켜 하기 화학식 2로 표시되는 디클로로화합물을 제조하는 S1단계와;
상기 디클로로화합물을 포타시움 아세테이트와, 포타시움 카보네이트와, N-메틸-2-피롤리디논과, 테트라뷰틸암모니움브로마이드와 반응시켜 하기 화학식 3으로 표시되는 클로로아세테이트화합물을 제조하는 S2단계와;
상기 클로로아세테이트화합물을 포타시움하이드록사이드와, 메탄올과, 팔라디움과 반응시켜 하기 화학식 4로 표시되는 알콜화합물을 제조하는 S3단계;
를 포함하는 것을 특징으로 하는 Etofenprox 중간체 제조방법.
[화학식 1]
Figure 112019055578015-pat00011

[화학식 2]
Figure 112019055578015-pat00012

[화학식 3]
Figure 112019055578015-pat00013

[화학식 4]
Figure 112019055578015-pat00014

Step S1 of preparing a dichloro compound represented by the following Chemical Formula 2 by reacting chloroethoxybenzene represented by the following Chemical Formula 1 with sulfuric acid and 3-chloro-2-methylpropene;
S2 step of preparing a chloroacetate compound represented by the following formula 3 by reacting the dichloro compound with potassium potassium, potassium potassium carbonate, N-methyl-2-pyrrolidinone, and tetra butyl ammonium bromide;
S3 step of preparing an alcohol compound represented by the following Chemical Formula 4 by reacting the chloroacetate compound with potassium potassium, methanol, and palladium;
Etofenprox intermediate production method comprising a.
[Formula 1]
Figure 112019055578015-pat00011

[Formula 2]
Figure 112019055578015-pat00012

[Formula 3]
Figure 112019055578015-pat00013

[Formula 4]
Figure 112019055578015-pat00014

삭제delete 삭제delete 삭제delete 청구항 1의 화학식 3으로 표시되는 2-(3-Chloro-4-ethoxyphenyl)-2-methylpropyl acetate.2- (3-Chloro-4-ethoxyphenyl) -2-methylpropyl acetate represented by Chemical Formula 3 of claim 1.
KR1020180035651A 2018-03-28 2018-03-28 Method for manufacturing Etofenprox intermediate KR102033852B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020180035651A KR102033852B1 (en) 2018-03-28 2018-03-28 Method for manufacturing Etofenprox intermediate

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020180035651A KR102033852B1 (en) 2018-03-28 2018-03-28 Method for manufacturing Etofenprox intermediate

Publications (2)

Publication Number Publication Date
KR20190113240A KR20190113240A (en) 2019-10-08
KR102033852B1 true KR102033852B1 (en) 2019-10-17

Family

ID=68209020

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020180035651A KR102033852B1 (en) 2018-03-28 2018-03-28 Method for manufacturing Etofenprox intermediate

Country Status (1)

Country Link
KR (1) KR102033852B1 (en)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS588005A (en) * 1981-07-07 1983-01-18 Earth Chem Corp Ltd Repellent for noxious insect
JPH02124843A (en) * 1988-11-02 1990-05-14 Mitsui Toatsu Chem Inc Production of 2-(4-alkoxyphenyl)-2-methylpropanols
US7015236B2 (en) 2001-11-21 2006-03-21 Sankyo Agro Company, Limited N-heteroarylnicotinamide derivatives
CA2935662A1 (en) 2014-01-31 2015-08-06 Basf Se Pyrazoles for controlling invertebrate pests
CN107428741B (en) 2014-12-22 2021-06-25 巴斯夫欧洲公司 Cyclic compounds substituted by condensed ring systems

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
ANIL KUMAR et al, 'Regio-Selective Synthesis of Key Intermediates of Fexofenadine', Asian J. Chem., 2015, Vol.27, No.6, pp. 2285-2287
Takeo Yoshimoto et al, 'Development of a New Insecticide, Etofenprox', Journal of Pesticide Science, 1989, Vol.14, No.2, pp.259-268

Also Published As

Publication number Publication date
KR20190113240A (en) 2019-10-08

Similar Documents

Publication Publication Date Title
CN102639486B (en) Process for manufacture of N-acylbphenyl alanine
CA2658652C (en) Novel process for the synthesis of (e)-stilbene derivatives which makes it possible to obtain resveratrol and piceatannol
EP2621888B1 (en) Methods of synthesizing 2- substituted-1,4-benzenediamine
CN102076651A (en) Method for producing substituted biphenyls
CN107417505B (en) Preparation method of alpha-halogenated tetramethyl cyclohexanone and (2,3,4, 4-tetramethylcyclopentyl) methyl carboxylic ester
JPS6240358B2 (en)
JP4039693B2 (en) A new process for preparing pesticide intermediates
KR102033852B1 (en) Method for manufacturing Etofenprox intermediate
KR840000416B1 (en) Process for the preparation of trifluoro methylphenyl nitrophenyl ethers
KR100339310B1 (en) Chemical Intermediates Useful for Agriculture
CN100509728C (en) Demethyl method of aryl methyl ether
KR101583851B1 (en) Method for producing 3-methyl-2-thiophenecarboxylic acid
KR20020094061A (en) Process for the preparation of aniline compounds
CN110734368A (en) Preparation method of buparvaquone
JP4727929B2 (en) Pyrazolylarylalkyne
CN102171201B (en) Method for producing spirocyclic tetronic acid derivatives
JP4568404B2 (en) Method for producing pyrazole carboxylic acid ester derivative
JPS6140660B2 (en)
KR20020040911A (en) Method for production of benzofuranone oximes
JPH09188637A (en) Production of 3-bromo-2-(substituted)-1-propene
US4211720A (en) Preparation of cyano-substituted cyclopropane derivatives
JP4396025B2 (en) Process for producing 4-methoxymethyl-2,3,5,6-tetrafluorobenzenemethanol
JP4125263B2 (en) Trioxymethylcarboxylic acids of trisphenols and their tertiary cyclopentyl esters
RU1689376C (en) Process for preparing 1r, 3s-2,2-dimethyl-3-(2- oxopropyl)cyclopropaneacetonitrile
JP3787821B2 (en) Method for producing benzamidoxime compound

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right